Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases

Background and objective A retrospective review of consecutive patients between January 2012 and December 2018 receiving hypofractionated stereotactic radiotherapy (HSRT) to the cavity after resection for brain metastases was performed.